The global health and wellness nutrition sector, valued at £189 billion in 2024, is expected to grow at a compound annual rate of 8.1% until 2028, according to Euromonitor. Applied Nutrition’s pretax profits for the 2024 financial year ending in July reached £26 million, a 40.5% increase from the previous year’s £18.5 million.
Strategic Move for LSE and Applied Nutrition
The IPO comes as a rare boost for the London stock market, which has seen several companies delist or shift to overseas markets. Applied Nutrition’s IPO, however, signals renewed interest in London listings, particularly from companies in the thriving health and wellness industry.
New non-executive chair Andy Bell expressed optimism about the company’s future. “An LSE float would help Applied Nutrition become a global health and wellness player,” Bell said. The company is confident that a public listing would raise brand awareness and provide a platform for further growth.
Applied Nutrition £500M IPO : Legal and Market Advisors
Applied Nutrition is being advised on the float by Addleshaw Goddard LLP, with a team led by Roger Hart, and Pinsent Masons LLP. Industry analysts expect strong interest from both institutional and retail investors, as the IPO will offer a rare opportunity for ordinary investors to buy into a growing sports supplement company.
